Duffy Sean P. sold $342K of OMDA
Duffy Sean P. (Chief Executive Officer) sold 17,258 shares of Omada Health, Inc. (OMDA) at an average of $19.82 ($19.00–$20.90, $0.34M total) across 4 trades over 2026-06-24 to 2026-06-26 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The CEO’s open-market sale totals ~$342K across 17,258 shares at prices ranging from ~$19.00 to ~$20.90, with a stated pre-arranged 10b5-1 plan.
Market read
This is a routine insider-selling disclosure; it may marginally influence sentiment but lacks new fundamental information.
What to watch
The filing doesn’t disclose any change in business outlook, guidance, or risk factors—so traders should avoid over-weighting it versus fundamentals.
Background
The article is a primary-source SEC Form 4 insider transaction for Omada Health, Inc. (OMDA).
Ticker impact
Omada Health CEO Sean Duffy sold $342.1K of OMDA shares in four trades under a pre-arranged 10b5-1 plan (6/24–6/26).
Low likelihood of a sustained price move solely from this Form 4 sale; any reaction is likely muted and short-lived.
The disclosure is an open-market sale by the CEO with an explicitly pre-arranged 10b5-1 plan, and the article contains no new operational, financial, or regulatory developments.
Market effects
No direct sector read-through; this is company-specific insider transaction data.
None indicated.
None indicated.
Counterpoint
Because it’s a 10b5-1 plan, the sale may reflect scheduled liquidity needs rather than bearish expectations.
Key entities
- public_companyOmada Health, Inc.
Issuer of the Form 4 insider transaction; CEO Sean Duffy sold shares under a 10b5-1 plan.
- insiderSean P. Duffy
Chief Executive Officer and officer/director who executed the open-market sales.
